Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Acute Intermittent Porphyria market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Intermittent Porphyriamarket, defines the market attractiveness level of Acute Intermittent Porphyria market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acute Intermittent Porphyria industry, describes the types of Acute Intermittent Porphyria market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Intermittent Porphyria market and the development prospects and opportunities of Acute Intermittent Porphyria industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Intermittent Porphyria market in Chapter 13.
By Player:
Roche
Dahaner
Bio-Rad Laboratories
ARKRAY
Sysmex Corporation
ACON Laboratories
Siemens
By Type:
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions
By End-User:
Hospitals & Clinics
Research Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acute Intermittent Porphyria Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acute Intermittent Porphyria Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acute Intermittent Porphyria Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acute Intermittent Porphyria Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acute Intermittent Porphyria Market Analysis and Outlook to 2022
-
7.1 Global Acute Intermittent Porphyria Consumption (2017-2022)
-
7.2 United States Acute Intermittent Porphyria Consumption (2017-2022)
-
7.3 Europe Acute Intermittent Porphyria Consumption (2017-2022)
-
7.4 China Acute Intermittent Porphyria Consumption (2017-2022)
-
7.5 Japan Acute Intermittent Porphyria Consumption (2017-2022)
-
7.6 India Acute Intermittent Porphyria Consumption (2017-2022)
-
7.7 South Korea Acute Intermittent Porphyria Consumption (2017-2022)
8 Region and Country-wise Acute Intermittent Porphyria Market Analysis and Outlook to 2028
-
8.1 Global Acute Intermittent Porphyria Consumption Forecast (2022-2028)
-
8.2 United States Acute Intermittent Porphyria Consumption Forecast (2022-2028)
-
8.3 Europe Acute Intermittent Porphyria Consumption Forecast (2022-2028)
-
8.4 China Acute Intermittent Porphyria Consumption Forecast (2022-2028)
-
8.5 Japan Acute Intermittent Porphyria Consumption Forecast (2022-2028)
-
8.6 India Acute Intermittent Porphyria Consumption Forecast (2022-2028)
-
8.7 South Korea Acute Intermittent Porphyria Consumption Forecast (2022-2028)
9 Global Acute Intermittent Porphyria Market Outlook by Types and Applications to 2022
-
9.1 Global Acute Intermittent Porphyria Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gonadotropin-Releasing Hormone Analogues Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prophylactic Hematin Infusions Consumption and Growth Rate (2017-2022)
-
9.2 Global Acute Intermittent Porphyria Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Centers Consumption and Growth Rate (2017-2022)
10 Global Acute Intermittent Porphyria Market Outlook by Types and Applications to 2028
-
10.1 Global Acute Intermittent Porphyria Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gonadotropin-Releasing Hormone Analogues Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prophylactic Hematin Infusions Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acute Intermittent Porphyria Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Acute Intermittent Porphyria Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acute Intermittent Porphyria Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acute Intermittent Porphyria Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acute Intermittent Porphyria Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acute Intermittent Porphyria Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche Acute Intermittent Porphyria Product and Service
-
14.2 Dahaner
-
14.2.1 Dahaner Company Details
-
14.2.2 Dahaner Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Dahaner Acute Intermittent Porphyria Product and Service
-
14.3 Bio-Rad Laboratories
-
14.3.1 Bio-Rad Laboratories Company Details
-
14.3.2 Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Product and Service
-
14.4 ARKRAY
-
14.4.1 ARKRAY Company Details
-
14.4.2 ARKRAY Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ARKRAY Acute Intermittent Porphyria Product and Service
-
14.5 Sysmex Corporation
-
14.5.1 Sysmex Corporation Company Details
-
14.5.2 Sysmex Corporation Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sysmex Corporation Acute Intermittent Porphyria Product and Service
-
14.6 ACON Laboratories
-
14.6.1 ACON Laboratories Company Details
-
14.6.2 ACON Laboratories Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ACON Laboratories Acute Intermittent Porphyria Product and Service
-
14.7 Siemens
-
14.7.1 Siemens Company Details
-
14.7.2 Siemens Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Siemens Acute Intermittent Porphyria Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acute Intermittent Porphyria
-
Figure Acute Intermittent Porphyria Picture
-
Table Global Acute Intermittent Porphyria Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Intermittent Porphyria Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Intermittent Porphyria Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acute Intermittent Porphyria Consumption by Country (2017-2022)
-
Figure United States Acute Intermittent Porphyria Consumption and Growth Rate (2017-2022)
-
Table Europe Acute Intermittent Porphyria Consumption and Growth Rate (2017-2022)
-
Figure China Acute Intermittent Porphyria Consumption and Growth Rate (2017-2022)
-
Figure Japan Acute Intermittent Porphyria Consumption and Growth Rate (2017-2022)
-
Figure India Acute Intermittent Porphyria Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acute Intermittent Porphyria Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Intermittent Porphyria Consumption Forecast by Country (2022-2028)
-
Figure United States Acute Intermittent Porphyria Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acute Intermittent Porphyria Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acute Intermittent Porphyria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acute Intermittent Porphyria Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acute Intermittent Porphyria Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acute Intermittent Porphyria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gonadotropin-Releasing Hormone Analogues Consumption and Growth Rate (2017-2022)
-
Figure Global Prophylactic Hematin Infusions Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Gonadotropin-Releasing Hormone Analogues Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prophylactic Hematin Infusions Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acute Intermittent Porphyria Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acute Intermittent Porphyria Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Acute Intermittent Porphyria Product and Service
-
Table Dahaner (Foundation Year, Company Profile and etc.)
-
Table Dahaner Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dahaner Acute Intermittent Porphyria Product and Service
-
Table Bio-Rad Laboratories (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Acute Intermittent Porphyria Product and Service
-
Table ARKRAY (Foundation Year, Company Profile and etc.)
-
Table ARKRAY Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table ARKRAY Acute Intermittent Porphyria Product and Service
-
Table Sysmex Corporation (Foundation Year, Company Profile and etc.)
-
Table Sysmex Corporation Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sysmex Corporation Acute Intermittent Porphyria Product and Service
-
Table ACON Laboratories (Foundation Year, Company Profile and etc.)
-
Table ACON Laboratories Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table ACON Laboratories Acute Intermittent Porphyria Product and Service
-
Table Siemens (Foundation Year, Company Profile and etc.)
-
Table Siemens Acute Intermittent Porphyria Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Acute Intermittent Porphyria Product and Service
-
